Supplementary Data from A Phase I Dose-Escalation Trial of BN-CV301, a Recombinant Poxviral Vaccine Targeting MUC1 and CEA with Costimulatory Molecules

Autor: James L. Gulley, Jeffrey Schlom, Christopher R. Heery, Cesar Pico Navarro, Eva Wagner, Andrea Burmeister, Alanvin Orpia, Elizabeth Lamping, Lisa M. Cordes, Jennifer L. Marté, Ravi A. Madan, Jason M. Redman, Jaydira Del Rivero, Claudia Palena, Renee N. Donahue, Julius Strauss, Margaret E. Gatti-Mays
Rok vydání: 2023
Popis: Supplementary Table S1A: Phenotypic analysis of surface markers on human DCs transfected with MVA-BN-CV301 and FPV-CV301 vectors Supplementary Table S1B: Activation of CEA- and MUC1-specific T-cells by MVA-BN-CV301 and FPV-CV301 Supplementary Table S2: Number of patients reporting adverse events possibly, probably or definitely attributed to CV301 (n=202 events in total) Supplementary Table S3: Development of CEA- and MUC1-specific T-cells by BN-CV301 Supplementary Figure S1: KRAS specific responses assessed in 3 patients preâ€' and postâ€'BN- CV301 vaccine
Databáze: OpenAIRE